ArbiLayer
ABBVX logo

AbbVie xStock

ABBVX Rank #4552
$267.62▲ 0.44%24h
Low $259.58High $270.29

Price chart

Loading price history…
Market cap$265.4KRank #4552
Fully diluted value$107.28M
Volume (24h)$21.9KVol / Mcap 8.23%
Circulating supply991.6223ABBVX
Total supply400.9K
Max supply∞no hard cap
All-time high$275.74Sep 26, 2026
All-time low$165.04Apr 11, 2026

What is AbbVie xStock?

Overview

ABBVX represents tokenized AbbVie stock, enabling users to gain direct exposure to the company's equity through blockchain infrastructure. The token provides a legal claim to the value of the underlying stock while remaining accessible to non-US investors and compliant with EU regulations. xStocks address traditional investing barriers by offering on-chain trading through decentralized and centralized exchanges without requiring traditional broker intermediaries.

How it works

ABBVX is deployed across multiple blockchain networks including Arbitrum, Ethereum, BNB Chain, Mantle, Solana, and The Open Network. Each token maintains a 1:1 backing with actual AbbVie shares, ensuring the cryptographic representation matches the underlying asset value. The token integrates with decentralized finance protocols, allowing it to be used as collateral or composable within smart contracts like any standard token.

Token and supply

Total supply is approximately 401 thousand tokens with circulating supply significantly lower. No maximum supply cap is documented.

Where to trade ABBVX

Exchanges that list this asset

All markets
#ExchangePairsVolume (24h)
Loading exchanges that list this asset…
Live spot quotes from connected exchanges
VenueBidAskMidStatus
Open to load live quotes.

ABBVX funding rates

Live perpetual funding on every connected exchange. Positive = longs pay shorts.

Full view

Contracts & chains

Exact contract or mint per network — the identity layer used for DEX routing.

Resolving token registry…

On-chain routes

Networks with a connected DEX routing adapter.

Loading DEX coverage…

AbbVie xStock news

All news
Loading related headlines…